Abstract
The habitual level of PAI-1 is influenced by many factors, of which obesity and insulin resistance are the most important. It is possible to reduce plasma PAI-1 by changes in life style, e.g. weight reduction and physical activity. Data on potential interactions between environmental and metabolic variables on one hand, and the 4G/5G-polymorphism on the other hand, are still scarce. It becomes more and more clear that PAI-1 may possibly not be a major (causal) factor in cardiovascular disease, but its role in inflammation deserves further attention. In the presence of the 4G-allele not only the PAI-1 response was more pronounced, but also the response of other acute-phase reactants, which implies that the increases of these reactants are secondary to the increase in PAI-1. A myocardial infarction also provokes an acute phase response. It can thus be hypothesized that the 4G-allele might exacerbate tissue injury during the acute phase after a myocardial infarction, and thereby negatively affect the prognosis
| Original language | English |
|---|---|
| Pages (from-to) | 861-872 |
| Journal | Thrombosis and Haemostasis |
| Volume | 91 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2004 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- hormone-replacement therapy
- human-endothelial-cells
- acute myocardial-infarction
- coronary-artery-disease
- human adipose-tissue
- healthy postmenopausal women
- 4g/5g promoter polymorphism
- insulin-resistance syndrome
- gene-environment interaction
- depende
Fingerprint
Dive into the research topics of 'Plasminogen activator inhibitor-type I: its plasma determinants and relation with cardiovascular risk'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver